Mark Aronica

3.8k citations
50 papers · 2.9k indexed · h-index 30

Mark Aronica

50 papers receiving 2.9k citations

Peers

Mark Aronica
Comparison fields: 5 of 116
  • Immunology 1.5k
  • Immunology and Allergy 186
  • Dermatology 258
  • Cancer Research 411
  • Physiology 708
Replace John A. Di Battista with:
John A. Di Battista Canada
Ilaria Puxeddu Italy
Stéphane Esnault United States
François Mineau Canada
Nobuhiro Nakano Japan
Dragan Jovanović Canada
Athanasia D. Panopoulos United States
Rieko Arakaki Japan
Christophe Desmet Belgium
Francescopaolo Granata Italy
Mark Aronica relative to John A. Di Battista Canada John A. Di Battista's profile →
Citations per field
00.5×1.5×2.0×
John A. Di Battista · 1×
Citations per year

Countries citing papers authored by Mark Aronica

Since Specialization
Citations

This map shows the geographic impact of Mark Aronica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Aronica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Aronica more than expected).

Fields of papers citing papers by Mark Aronica

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Aronica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Aronica. The network helps show where Mark Aronica may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Aronica, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Aronica Line = papers co-authored together Mark Aronica links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201914
2 201997
3 201813
4 201724
5 20162
6 201633
7 201534
8 201526
9 201259
10 201243
11 201254
12 201021
13 201020
14 2009110
15 200729
16 2006160
17 20046
18 200319
19 200382
20 200030

About Mark Aronica

Mark Aronica is a scholar working on Immunology, Physiology, Equine, Cancer Research and Cell Biology, having authored 50 papers that have together received 2.9k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (28 papers), IL-33, ST2, and ILC Pathways (14 papers), Immune Cell Function and Interaction (14 papers), NF-κB Signaling Pathways (8 papers), Proteoglycans and glycosaminoglycans research (8 papers), Neonatal Respiratory Health Research (6 papers), Immune Response and Inflammation (6 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Immunology (1.5k citations), Immunology and Allergy (186 citations), Dermatology (258 citations), Cancer Research (411 citations) and Physiology (708 citations). Mark Aronica has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Shadi Swaidani, Xiaoxia Li, Mark Boothby, Katarzyna Bulek, Caini Liu, Muhammet F. Gülen, Ana L. Mora, Serpil C. Erzurum, James R. Sheller and Mark Lauer. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, Journal of Allergy and Clinical Immunology, Cytokine and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026